DGAP-News: Apricus Bioscience–s Wholly-Owned Subsidiary NexMed (USA) Signs Exclusive German Collaboration for Vitaros(R) for Erectile Dysfunction
Apricus Biosciences, Inc.
16.02.2012 01:19
—————————————————————————
SAN DIEGO, 2012-02-16 01:19 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that its wholly-owned subsidiary
NexMed(USA), Inc. has signed with Sandoz, a division of Novartis, an exclusive
collaboration for Germany to market Apricus Bio–s Vitaros(r) drug for the
treatment of erect
